Patent Pending Ingredient Positions CULT Food Science For Potential Joint Ventures, Supply Agreements and Royalty Streams

TORONTO, April 18, 2023 /PRNewswire/ - CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN0), a pioneer in the investment, development, and commercialization of cellular agriculture technologies and products, is pleased to announce details and commercialization plans for its proprietary and patent-pending Bmmune™ product. Bmmune™ is an alternative protein source for pet food made through a natural fermentation process and is patented for its freeze-dried pet treats. The acquisition of Bmmune™ was previously announced by the Company on March 28, 2023.

Cult Food Science Corp. Logo (CNW Group/CULT Food Science Corp.)

The patent covers the nutritional and functional properties of Bmmune™, which is produced using nutritional yeast and koji, a fermented protein derived from Aspergillus niger. Bmmune™ delivers high-quality and sustainable protein for cats and dogs, with nutrient specifications similar to conventional meat. Additionally, Bmmune™ has been shown to provide health benefits to pets, including improved digestion, gut health, immune system support, cognitive, arterial and heart health, among others.                                                               

The overwhelming majority of the estimated US$99-billion global pet food market is based on farmed animal protein. But those conventional foods are falling short of consumer expectations around pet nutrition, are environmentally hazardous and face supply chain constraints. In recent years, pet foods based on alternative proteins have become a high-growth segment of the industry. These treats, supplements and food products avoid the unsustainable factory farming system altogether and rely mostly on plant proteins thus far. Pet owners see nutritive benefits in avoiding animal byproducts and meats coming from dead, dying or diseased farmed animals. Pet foods that contain farmed animal meat have a heavy toll on the environment, estimated to emit as many as 64 million tons of greenhouse gases into the atmosphere every year. And throughout the pandemic, the meat supply chain for pet foods was significantly throttled, causing shortages that persist today.

Pet products formulated with Bmmune™ have all the same environmental benefits of plant-based proteins, but can be more palatable, higher protein and have been shown to have been shown to have better absorption rates in dogs.

Management Commentary

"This is one of many foundational patents that CULT Food Science will utilize to continue to build the future of food. The versatility of Bmmune™ will serve as a platform for multiple products. " said Lejjy Gafour, CEO of CULT.

"It is still difficult to create pet foods that deliver premium, palatable nutrition to dogs and cats and have a low carbon footprint. With Bmmune™, we've solved at least part of this complex problem," said Joshua Errett, VP of Product Development at CULT. "We are now ready to supply Bmmune™ to plant-based and conventional pet brands as a way to enhance protein content, increase palatability, drive down ingredient costs and improve sustainability in pet foods."

About CULT Food Science                                                            

CULT Food Science Corp. is the first publicly-traded company of its kind in North America, pioneering the investment, development, and commercialization of cellular agriculture technologies and products. Through its global portfolio of companies and its venture studio, CULT Food Science provides investors with unprecedented exposure to the most innovative start-up, private or early-stage cultivated meat, cell-based dairy, and other cultured food companies around the world.

Additional information can be found by viewing the Company's website at or its regulatory filings on

On behalf of the Board of Directors of the Company,


"Lejjy Gafour"
Lejjy Gafour, Chief Executive Officer

Forward-Looking Information:

Information set forth in this news release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company's expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include but are not limited to the following risks: those associated with marketing and sale of securities; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; and the volatility of common share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. For further information on risk, investors are advised to see the Company's MD&A and other disclosure filings with the regulators which are found at

Cision View original content to download multimedia:

SOURCE CULT Food Science Corp.